2 Eylül 2024 Konferans bildirisi Açık Erişim

Çelekli, Abuzer; Habash, Ihssan

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <controlfield tag="005">20240902135340.0</controlfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:aperta.ulakbim.gov.tr:273865</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Gaziantep University</subfield>
    <subfield code="a">Çelekli, Abuzer</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Obesity is a chronic metabolic disorder marked by the excessive accumulation of body fat, presenting a significant threat to overall health. This review aims to provide a comprehensive examination of obesity by investigating its underlying causes, associated comorbidities, and treatment options. Additionally, it explores the complex relationship between obesity and oxidative stress, focusing on how obesity affects oxidative stress markers and the subsequent impact on health outcomes. The review begins with an analysis of the primary causes of obesity, which include genetic predispositions, environmental factors, behavioral patterns, and socioeconomic influences. These factors contribute to the development and persistence of obesity by affecting energy balance, fat storage, and metabolic processes. Understanding the connection between oxidative stress and obesity takes up a large amount of the review. The pathophysiology of obesity heavily relies on oxidative stress, which is defined as an imbalance between antioxidant defenses and reactive oxygen and nitrogen species (ROS/RNS). We examine how increased adiposity influences oxidative stress markers, leading to cellular oxidative damage, inflammation, and metabolic dysfunction. In conclusion, this review offers a thorough analysis of obesity, emphasizing its causes, associated health issues, and the intricate relationship between obesity and oxidative stress.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[1] W.H. Organization, Obesity: preventing and managing the global epidemic. Report of a WHO consultation., World  Health Organization - Technical Report Series. 894 (2000).</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[2] N.F. Butte, K.J. Ellis, Comment on "Obesity and the environment: where do we go from here?"., Science. 301 (2003)  853–855. https://doi.org/10.1126/science.1085985.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[3] B.A. Swinburn, G. Sacks, K.D. Hall, K. McPherson, D.T. Finegood, M.L. Moodie, S.L. Gortmaker, The global obesity  pandemic: Shaped by global drivers and local environments, The Lancet. 378 (2011) 804–814.  https://doi.org/10.1016/S0140-6736(11)60813-1.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[4] M.D. Jensen, D.H. Ryan, C.M. Apovian, Erratum: AHA/ACC/TOS Guideline for the Management of Overweight and  Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on  Practice Guidelines and the Obesity Society (Journal of the American College of Cardiology (2013) DOI  10.1016/j.jacc.2013.11.004), Journal of the American College of Cardiology. 63 (2014) 3029–3030.  https://doi.org/10.1016/j.jacc.2014.03.004.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[5] S. Cuda, M. Censani, Progress in pediatric obesity: New and advanced therapies, Current Opinion in Pediatrics. 34  (2022) 407–413. https://doi.org/10.1097/MOP.0000000000001150.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[6] G.A. Bray, K.K. Kim, J.P.H. Wilding, Obesity: a chronic relapsing progressive disease process. A position statement  of the World Obesity Federation, Obesity Reviews. 18 (2017) 715–723. https://doi.org/10.1111/obr.12551.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[7] B. Matthias, Obesity: global epidemiology and pathogenesis, Nature Reviews. Endocrinology. 15 (2019) 288–298.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[8] A.S. Jackson, P.R. Stanforth, J. Gagnon, T. Rankinen, A.S. Leon, D.C. Rao, J.S. Skinner, C. Bouchard, J.H. Wilmore,  The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study,  International Journal of Obesity. 26 (2002) 789–796. https://doi.org/10.1038/sj.ijo.0802006.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[9] M.F. Najjar, M. Rowland, Anthropometric reference data and prevalence of overweight, United States, 1976-80., Vital  and Health Statistics. Series 11, Data from the National Health Survey. (1987) 1–73.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[10] M. Blüher, Adipose tissue dysfunction contributes to obesity related metabolic diseases, Best Practice and Research:  1170 Clinical Endocrinology and Metabolism. 27 (2013) 163–177. https://doi.org/10.1016/j.beem.2013.02.005.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[11] S. De Ferranti, D. Mozaffarian, The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences,  Clinical Chemistry. 54 (2008) 945–955. https://doi.org/10.1373/clinchem.2007.100156.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[12] M.P. Fitzgerald, K. Hennigan, C.S. O'Gorman, L. McCarron, Obesity, diet and lifestyle in 9-year-old children with  parentally reported chronic diseases: findings from the Growing Up in Ireland longitudinal child cohort study, Irish  Journal of Medical Science. 188 (2019) 29–34. https://doi.org/10.1007/s11845-018-1814-1.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[13] M.E. Romero-Ibarguengoitia, F. Vadillo-Ortega, A.E. Caballero, I. Ibarra-González, A. Herrera-Rosas, M.F. SerratosCanales, M. León-Hernández, A. González-Chávez, S. Mummidi, R. Duggirala, J.C. López-Alvarenga, Correction:  Family history and obesity in youth, their effect on acylcarnitine/ aminoacids metabolomics and non-alcoholic fatty  liver disease (NAFLD). Structural equation modeling approach (PLoS ONE (2018) 13:2 (e0193138) DOI:  10.1371/journal.pone.0193138), PLoS ONE. 13 (2018) e0193138. https://doi.org/10.1371/journal.pone.0198379.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[14] A. Çelekli, İ. Yeşildağ, S. Yaygır, Ö.E. Zariç, Effects of urbanization on bioclimatic comfort conditions, Acta  Biologica Turcica. 36 (2023) 2-1–9.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[15] M.F. Dallman, Stress-induced obesity and the emotional nervous system, Trends in Endocrinology and Metabolism. 21  (2010) 159–165. https://doi.org/10.1016/j.tem.2009.10.004.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[16] J. Newell-Price, X. Bertagna, A.B. Grossman, L.K. Nieman, Cushing's syndrome, The Lancet. 367 (2006) 1605–1617.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[17] O. Løvsletten, B.K. Jacobsen, S. Grimsgaard, I. Njølstad, T. Wilsgaard, M.L. Løchen, A.E. Eggen, L.A. Hopstock,  Prevalence of general and abdominal obesity in 2015-2016 and 8-year longitudinal weight and waist circumference  changes in adults and elderly: The Tromsø Study, BMJ Open. 10 (2020) e038465. https://doi.org/10.1136/bmjopen2020-038465.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[18] D.P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C.L. Birmingham, A.H. Anis, The incidence of co-morbidities related  to obesity and overweight: A systematic review and meta-analysis, BMC Public Health. 9 (2009) 1–20.  https://doi.org/10.1186/1471-2458-9-88.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[19] M.M. Finucane, G.A. Stevens, M.J. Cowan, G. Danaei, J.K. Lin, C.J. Paciorek, G.M. Singh, H.R. Gutierrez, Y. Lu,  A.N. Bahalim, F. Farzadfa, L.M. Riley, M. Ezzati, Re: National, regional, and global trends in body-mass index since  1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1  million participants, Journal of Urology. 186 (2011) 1982–1983. https://doi.org/10.1016/j.juro.2011.07.061.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[20] J.A. Skelton, W.J. Klish, Overview of the health consequences of obesity in children and adolescents, UpToDate.  (2020) 1–55. https://www.uptodate.com/contents/overview-of-the-health-consequences-of-obesity-in-children-andadolescents.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[21] A. Ataey, E. Jafarvand, D. Adham, E. Moradi-Asl, The relationship between obesity, overweight, and the human  development index in world health organization eastern mediterranean region countries, Journal of Preventive  Medicine and Public Health. 53 (2020) 98–105. https://doi.org/10.3961/jpmph.19.100.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[22] E.M. Inelmen, G. Sergi, A. Coin, F. Miotto, S. Peruzza, G. Enzi, Can obesity be a risk factor in elderly people?,  Obesity Reviews. 4 (2003) 147–155. https://doi.org/10.1046/j.1467-789X.2003.00107.x.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[23] C.D. Fryar, M.D. Carroll, C.L. Ogden, Prevalence of Overweight, Obesity, and Severe Obesity Among Children and  Adolescents Aged 2–19 Years: United States, 1963–1965 Through 2015–2016, National Center for Health Statistics  Health E-Stats. (2018) 1–6.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[24] S. Telles, B.N. Gangadhar, K.D. Chandwani, Lifestyle Modification in the Prevention and Management of Obesity,  Journal of Obesity. 2016 (2016). https://doi.org/10.1155/2016/5818601.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[25] M. Benedetti, V. Vecchi, S. Barera, L. Dall'Osto, Biomass from microalgae: The potential of domestication towards  sustainable biofactories, Microbial Cell Factories. 17 (2018) 1–18. https://doi.org/10.1186/s12934-018-1019-3.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[26] P. Lee, B.R. Yacyshyn, M.B. Yacyshyn, Gut microbiota and obesity: An opportunity to alter obesity through faecal  microbiota transplant (FMT), Diabetes, Obesity and Metabolism. 21 (2019) 479–490.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[27] K.S. McClendon, D.M. Riche, G.I. Uwaifo, Orlistat: current status in clinical therapeutics., Expert Opinion on Drug  Safety. 8 (2009) 727–744. https://doi.org/10.1517/14740330903321485.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[28] FDA, SAXENDA (liraglutide) injection, Interactions. 50 (1998) 1–25. http://pi.lilly.com/us/zyprexa-pi.pdf.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[29] C.M. Apovian, Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes, Future Cardiology.  1171 12 (2016) 129–138.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[30] J.H. Shin, K.M. Gadde, Clinical utility of phentermine/topiramate (QsymiaTM) combination for the treatment of  obesity, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. (2013) 131–139.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[31] N. Giruzzi, Plenity (oral superabsorbent hydrogel), Clinical Diabetes: A Publication of the American Diabetes  Association. 38 (2020) 313.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[32] A. Markham, Setmelanotide: first approval, Drugs. 81 (2021) 397–403</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[33] G. Gomez, F.C. Stanford, US health policy and prescription drug coverage of FDA-approved medications for the  treatment of obesity, International Journal of Obesity. 42 (2018) 495–500. https://doi.org/10.1038/ijo.2017.287.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[34] P.G. Kopelman, Obesity as a medical problem, Nature. 404 (2000) 635–643. https://doi.org/10.1038/35007508.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[35] A.C. Barr, K.L. Lak, M.C. Helm, T.L. Kindel, R.M. Higgins, J.C. Gould, Linear vs. circular-stapled gastrojejunostomy  in Roux-en-Y gastric bypass, Surgical Endoscopy. 33 (2019) 4098–4101. https://doi.org/10.1007/s00464-019-06712-2.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[36] W.P.T. James, Obesity: A global public health challenge, Clinical Chemistry. 64 (2018) 24–29.  https://doi.org/10.1373/clinchem.2017.273052.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[37] A. Çelekli, Ö.E. Zariç, Assessing the environmental impact of functional foods, in: 6th International Eurasian  Conference on Biological and Chemical Sciences, 2023: p. 103.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[38] D. Mohajan, H.K. Mohajan, Obesity and Its Related Diseases: A New Escalating Alarming in Global Health, Journal  of Innovations in Medical Research. 2 (2023) 12–23. https://doi.org/10.56397/jimr/2023.03.04.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[39] M. Lawson, K. Jomova, P. Poprac, K. Kuca, K. Musílek, M. Valko, Free radicals and antioxidants in human disease,  Nutritional Antioxidant Therapies: Treatments and Perspectives. 39 (2018) 283–305. https://doi.org/10.1007/978-3- 319-67625-8_12.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[40] K.C. Waterman, R.C. Adami, K.M. Alsante, J. Hong, M.S. Landis, F. Lombardo, C.J. Roberts, Stabilization of  pharmaceuticals to oxidative degradation, Pharmaceutical Development and Technology. 7 (2002) 1–32.  https://doi.org/10.1081/PDT-120002237.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[41] M. Carocho, I.C.F.R. Ferreira, A review on antioxidants, prooxidants and related controversy: Natural and synthetic  compounds, screening and analysis methodologies and future perspectives, Food and Chemical Toxicology. 51 (2013)  15–25. https://doi.org/10.1016/j.fct.2012.09.021.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[42] Y. Liel, E. Ulmer, J. Shary, B.W. Hollis, N.H. Bell, Low circulating vitamin D in obesity, Calcified Tissue  International. 43 (1988) 199–201. https://doi.org/10.1007/BF02555135.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[43] I. Savini, M.V. Catani, D. Evangelista, V. Gasperi, L. Avigliano, Obesity-associated oxidative stress: Strategies  finalized to improve redox state, International Journal of Molecular Sciences. 14 (2013) 10497–10538.  https://doi.org/10.3390/ijms140510497.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[44] M. Ashwell, S.D. Hsieh, Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health  risks of obesity and how its use could simplify the international public health message on obesity, International Journal  of Food Sciences and Nutrition. 56 (2005) 303–307. https://doi.org/10.1080/09637480500195066.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[45] C.M.Y. Lee, R.R. Huxley, R.P. Wildman, M. Woodward, Indices of abdominal obesity are better discriminators of  cardiovascular risk factors than BMI: a meta-analysis, Journal of Clinical Epidemiology. 61 (2008) 646–653.  https://doi.org/10.1016/j.jclinepi.2007.08.012.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[46] A.A. Hedley, C.L. Ogden, C.L. Johnson, M.D. Carroll, L.R. Curtin, K.M. Flegal, Prevalence of overweight and obesity  among US children, adolescents, and adults, 1999-2002, Journal of the American Medical Association. 291 (2004)  2847–2850. https://doi.org/10.1001/jama.291.23.2847.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[47] A.H. Mokdad, J.S. Marks, D.F. Stroup, J.L. Gerberding, Actual Causes of Death in the United States, 2000, Journal of  the American Medical Association. 291 (2004) 1238–1245. https://doi.org/10.1001/jama.291.10.1238.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[48] M. Wei, J.B. Kampert, C.E. Barlow, M.Z. Nichaman, L.W. Gibbons, R.S. Paffenbarger, S.N. Blair, Relationship  between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men, Jama. 282 (1999)  1547–1553. https://doi.org/10.1001/jama.282.16.1547.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[49] K. Clark, The effect of age on the association between body-mass index and mortality., Journal of Insurance Medicine  (New York, N.Y.). 30 (1998) 48–49. https://doi.org/10.1056/nejm199801013380101.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[50] A. Misra, J.S. Wasir, N.K. Vikram, Waist circumference criteria for the diagnosis of abdominal obesity are not  applicable uniformly to all populations and ethnic groups, Nutrition. 21 (2005) 969–976.  https://doi.org/10.1016/j.nut.2005.01.007.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[51] S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M.  Matsuda, I. Shimomura, Increased oxidative stress in obesity and its impact on metabolic syndrome, Journal of Clinical  Investigation. 114 (2004) 1752–1761. https://doi.org/10.1172/JCI21625.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[52] H.K. Vincent, A.G. Taylor, Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans,  International Journal of Obesity. 30 (2006) 400–418. https://doi.org/10.1038/sj.ijo.0803177.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[53] S.O. Olusi, Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte  cytoprotectic enzymes in humans, International Journal of Obesity. 26 (2002) 1159–1164.  https://doi.org/10.1038/sj.ijo.0802066.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[54] M. Ozata, M. Mergen, C. Oktenli, A. Aydin, S.Y. Sanisoglu, E. Bolu, M.I. Yilmaz, A. Sayal, A. Isimer, I.C. Ozdemir,  Increased oxidative stress and hypozincemia in male obesity, Clinical Biochemistry. 35 (2002) 627–631.  https://doi.org/10.1016/S0009-9120(02)00363-6.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[55] V.D. Yumuk, National prevalence of obesity: Prevalence of obesity in Turkey, Obesity Reviews. 6 (2005) 9–10.  https://doi.org/10.1111/j.1467-789X.2005.00172.x.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[56] J. Warolin, K.R. Coenen, J.L. Kantor, L.E. Whitaker, L. Wang, S.A. Acra, L.J. Roberts, M.S. Buchowski, The  relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth,  Pediatric Obesity. 9 (2014) 43–52. https://doi.org/10.1111/j.2047-6310.2012.00135.x.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[57] M. Krzystek-Korpacka, E. Patryn, D. Boehm, I. Berdowska, B. Zielinski, A. Noczynska, Advanced oxidation protein  products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction, Clinical Biochemistry.  41 (2008) 943–949. https://doi.org/10.1016/j.clinbiochem.2008.04.024.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[58] P. Codoñer-Franch, S. Tavárez-Alonso, R. Murria-Estal, M. Tortajada-Girbés, R. Simó-Jordá, E. Alonso-Iglesias,  Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children, Nutrition,  Metabolism and Cardiovascular Diseases. 22 (2012) 237–243. https://doi.org/10.1016/j.numecd.2010.06.002.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">[59] L.A. Brown, C. J. Kerr, P. Whiting, N. Finer, J. McEneny, T. Ashton, Oxidant stress in healthy normal-weight,  overweight and obese individuals, Obesity. 17 (2009) 460–466. https://doi.org/10.1038/oby.2008.590</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="a">10.48623/aperta.273864</subfield>
    <subfield code="i">isVersionOf</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by-nc-nd/4.0/</subfield>
    <subfield code="a">Creative Commons Attribution-NonCommercial-NoDerivatives</subfield>
  </datafield>
  <controlfield tag="001">273865</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">conferencepaper</subfield>
  </datafield>
  <datafield tag="711" ind1=" " ind2=" ">
    <subfield code="g">ICEANS</subfield>
    <subfield code="a">5th International Conference on Engineering and Applied Natural Sciences</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Obesity and Oxidative Stress</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2024-09-02</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Gaziantep University</subfield>
    <subfield code="a">Habash, Ihssan</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/273865/files/ihsan.pdf</subfield>
    <subfield code="s">642198</subfield>
    <subfield code="z">md5:7465fa7d303140566fb7effafcb6eeeb</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.48623/aperta.273865</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
</record>